Enhancement of Lymphokine-Activated Killer Cell Cytotoxicity Implicated in the Increased Expression of Surface Adhesion Molecules on Tumor Cells Treated with Anticancer Agents

References

• Grimm E. A., Mazumder A., Zhang H. Z., et al. Lymphokine activated killer cell phenomenon: Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155: 1823–1841
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A., Lotze M. T., Muul L. M., et al. Observations on the systemic administration of aulologous lymphokine-activated killer cells and recombinant interleukin 2 to patients with metastatic cancer. N Engl J Med 1985; 313: 1485–1492
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A., Lotze M. T., Muul L. M., et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987; 316: 889–897
   PubMed Web of Science ®Google Scholar
• Berd D., Mastrangelo M., Engstrom P., et al. Augmentation of the human immune response by cyclophosphamide. Cancer Res 1982; 42: 4862–4867
   PubMed Web of Science ®Google Scholar
• Ehrke M. J., Mihich E. Immunoregulation by cancer chemotherapeutic agents. The Reticuloendothelial System: A Comprehensive Treatise, J. W. Hadder, A. Szentivanyi. Plenum Press, New York 1985; Vol. 8: 309–347
   Google Scholar
• Morikawa K., Hosokawa M., Hamada J., et al. Host-mediated therapeutic effects produced by appropriately limed administration of bleomycin on a rat fibrosarcoma. Cancer Res 1985; 45: 1502–1506
   PubMed Web of Science ®Google Scholar
• Sloychkov J. M., Sclutz R. M., Chirigos M. A., et al. Effect of adriamycin and cyclophosphamide treatmenl on induction of macrophagecytotoxic function in mice. Cancer Res 1979; 39: 3014–3019
   PubMed Web of Science ®Google Scholar
• Ogura T., Shindo H., Shinzato O., et al. In vitro tumor cell killing by peritoneal macrophages from mitomycin C treated rats. Cancer Immunol Immunother 1982; 13: 112–117
   PubMed Web of Science ®Google Scholar
• Kiyohara T., Taniguchi K., Kubota S., et al. Induction of lymphokine-activated killer-like cells by cancer chemotherapy. J Exp Med 1988; 168: 2355–2360
   PubMed Web of Science ®Google Scholar
• Liechtenstein A. K., Peude D. Enhancement of natural killer cylotoxicity by cis-diamminedichloroplatinum (II). Cancer Res 1980; 40: 3099–3102
   PubMedGoogle Scholar
• Matheson D. S., Green B., Hoar D. J. The influence of metholrexate and thymidine on the human natural killer cell function in vivo. J Immunol 1983; 131: 1619–1621
   PubMed Web of Science ®Google Scholar
• Hosokawa M., Sawamura Y., Morikage T., et al. Improved therapeutic effects of interleukin-2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide. Cancer Immunol Immunother 1988; 26: 250–256
   PubMed Web of Science ®Google Scholar
• Kawala A., Hosokawa M., Sawamura Y., et al. Modification of lymphokine activated killer cell accumulation into tumor sites by chemotherapy, local irradiation or splenectomy. Mol Biother 1990; 2: 221–227
   PubMedGoogle Scholar
• Yamaue H., Tanimura H., Noguchi K., et al. Cisplatin treatment renders tumor cells more susceptible to attack by lymphokine-activaled killer cells. J Clin Lab Immunol 1991; 35: 165–170
   PubMedGoogle Scholar
• Mizutani Y., Bonavida B., Nio Y., et al. Enhanced susceptibility of cis-diaminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells. Cancer 1993; 71: 1313–1321
   PubMed Web of Science ®Google Scholar
• Makgoba M. W., Sanders M. E., Ginter-Luce G. E., et al. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T-cell-mediated cytotoxicity. Eur J Immunol 1988; 18: 637–640
   PubMed Web of Science ®Google Scholar
• Show S., Luce G. E., Quinones R., et al. Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones. Nature 1986; 323: 262–264
   PubMed Web of Science ®Google Scholar
• Altomonte M., Gloghim A., Bertola G., et al. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaclion with cytotoxic cells. Cancer Res 1993; 53: 3343–3348
   PubMed Web of Science ®Google Scholar
• Jett J. H., Stevenson A. P., Warner N. L., et al. Quantitation of cell surface antigen density by flow cytometry. Flow Cytom 1980; 4: 215–221
   Google Scholar
• Chirgwin J. M., Przybyla A. E., MacDonald R. J., et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Thomas P. S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 1980; 77: 5201
   PubMed Web of Science ®Google Scholar
• Saitki R. K., Scharf S., Falcona F., et al. Enzymatic amplification of b-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350–1354
   PubMed Web of Science ®Google Scholar
• Iwasaki K. Studies on lymphokine-activated killer (LAK) activity and adoptive immunotherapy by LAK cells in patients with cancer in digestive organ. Fukushima Med J 1990; 40: 405–417
   Google Scholar
• Kameyama K., Takezaki S., Kanzaki T., et al. HLA-DR and melanoma-associated antigen (p97) expression during the cell cycle in human melanoma cell lines, and the effects of recombinant gammainterferon: Two-color flow cytometric analysis. J Invest Dermatol 1986; 87: 313–318
   PubMed Web of Science ®Google Scholar
• Zwelling L. A. Mechanism of action of cis-diamminedichloroplatinum (II). Cancer Treat Rep 1979; 663: 1439–1444
   Google Scholar
• Kontani H. Effect of mitomycin C on nucleic acid biosynthesis in Ehrlich ascites tumor cells. Biken J 1964; 7: 9–20
   PubMedGoogle Scholar
• Ciaran P., Kelly J., O'keane C., et al. Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. Am J Physiol 1992; 263: 864–870
   Google Scholar
• Frederic M., Marc F. Regulation of HLA-DR gene by IFN-g transcriptional and post-transcriptional control. J Immunol 1988; 140: 1660–1664
   PubMed Web of Science ®Google Scholar
• Tomita Y., Watanabe H., Kobayashi H., et al. Expression of intercellular adhesion molecule-1 on transitional cell cancer. Am J Pathol 1993; 143: 191–198
   PubMed Web of Science ®Google Scholar
• Schwartz H. S., Sodergren J. E., Ambaye R. Y. Actinomycin D drug concentrations and actions in mouse tissues and tumors. Cancer Res 1968; 28: 192–197
   PubMed Web of Science ®Google Scholar